S 4430
117th Congress
Senate
Commerce
Administrative remedies
Department of Commerce
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Intellectual property
Intergovernmental relations
Interagency Patent Coordination and Improvement Act of 2022
Introduced: June 16, 2022
Introduced by:
Durbin, Richard J.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 2, 2022
Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.
Aug 2, 2022
Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
Jul 28, 2022
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Jun 16, 2022
Read twice and referred to the Committee on the Judiciary.
Jun 16, 2022
Introduced in Senate
Plain-English summary
Interagency Patent Coordination and Improvement Act of 2022
This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include establishing a process for the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.
Committees of jurisdiction
1